U.S. News & World Report writers have truly taken notice of neurofeedback, especially as a treatment for ADHD. Last month, we reported that U.S. News and World Report Lists Neurofeedback As 1 of 9 Drug Free Treatments For ADHD. This recent attention is well deserved given that new research suggests that neurofeedback is an efficacious treatment for ADHD. For example, read Neurofeedback for ADHD Achieves A “Level 5 – Efficacious and Specific Efficacy Rating” previously reported on this website. Today, we highlight the latest neurofeedback story that appeared on this prominent news source’s website last month as: “Neurofeedback: An ADHD Treatment That Retrains the Brain? Neurofeedback hasn’t yet proved out and isn’t cheap, but it dangles the prospect of a permanent cure.” Check the end of this review for a link to the original article.
The author gives a basic and fairly accurate description of a typical neurofeedback session that includes the possibility to watch your favorite DVD movies. Lynda Thompson (wife of Michael Thompson, M.D.), a noted psychologist and presenter and the director of a Toronto ADHD center, is briefly interviewed, presumably to give added credibility. The author further explains that questionably designed (at least by medical standards) neurofeedback studies have been heretofore the only evidence that neurofeedback, or EEG biofeedback, is effective for ADHD, but that recent well-designed studies have demonstrated good results. The possibility that neurofeedback might replace or at least compliment psycho-stimulant medication is explored. A German ADHD study is mentioned without a reference; however, this may be Children With ADHD Realize Significant Benefits From Neurofeedback Training In a Randomized Clinical Trial reviewed here back in February. Last, they interview a mother that discusses the positive benefits that her child with ADHD experienced from neurofeedback.
Overall, this is very positive coverage of neurofeedback!
Visit the U.S. News & Word Report article here.
Enjoy.
No comments yet.